|
Impact of FDG-PET/CT on Management of Patients with Native Valve Infective Endocarditis
RECRUITINGSponsored by Montreal Heart Institute
Actively Recruiting
SponsorMontreal Heart Institute
Started2021-08-31
Est. completion2025-12-31
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT04792281
Summary
The proposed study is a multicentric prospective observational cohort study of patients with suspected NVE. The study population includes those with Possible IE according to the modified Duke criteria and investigated at one of the 6 participating sites which include 2 cardiac centers, the MHI and the IUCPQ, as well as 4 tertiary care centers, the Jewish General Hospital , the McGill University Health Centre and the CHUS.
Eligibility
Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria: * 18 years of age or older, capable to provide informed consent; * Referred for a FDG-PET/CT study * Classified as having Possible IE prior to FDG-PET/CT imaging; * Patients must be able to tolerate the physical/logistical requirements of a PET/CT scan. Exclusion Criteria: * Subjects with prosthetic cardiac valve and/or CIED; * Pregnant or breastfeeding female; * Body mass index \> 45 kg/m2.
Conditions3
Heart DiseaseInfective EndocarditisNative Valve Endocarditis
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorMontreal Heart Institute
Started2021-08-31
Est. completion2025-12-31
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT04792281